KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Imax (IMAX) Cash from Financing Activities (2016 - 2025)

Imax (IMAX) has disclosed Cash from Financing Activities for 16 consecutive years, with -$13.7 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities fell 169.12% to -$13.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$34.1 million through Dec 2025, down 464.13% year-over-year, with the annual reading at -$34.1 million for FY2025, 464.13% down from the prior year.
  • Cash from Financing Activities hit -$13.7 million in Q4 2025 for Imax, up from -$20.9 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $22.8 million in Q1 2024 to a low of -$52.6 million in Q1 2021.
  • Historically, Cash from Financing Activities has averaged -$14.0 million across 5 years, with a median of -$13.4 million in 2022.
  • Biggest five-year swings in Cash from Financing Activities: crashed 1158.96% in 2021 and later soared 251.59% in 2024.
  • Year by year, Cash from Financing Activities stood at -$22.2 million in 2021, then soared by 127.35% to $6.1 million in 2022, then tumbled by 497.65% to -$24.2 million in 2023, then soared by 78.95% to -$5.1 million in 2024, then plummeted by 169.12% to -$13.7 million in 2025.
  • Business Quant data shows Cash from Financing Activities for IMAX at -$13.7 million in Q4 2025, -$20.9 million in Q3 2025, and -$3.8 million in Q2 2025.